These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31880942)

  • 1. Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer.
    Wang L; Fang K; Cheng J; Li Y; Huang Y; Chen S; Dong G; Wu S; Sheng C
    J Med Chem; 2020 Jan; 63(2):696-713. PubMed ID: 31880942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents.
    Wang S; Fang K; Dong G; Chen S; Liu N; Miao Z; Yao J; Li J; Zhang W; Sheng C
    J Med Chem; 2015 Aug; 58(16):6678-96. PubMed ID: 26226379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural simplification of evodiamine: Discovery of novel tetrahydro-β-carboline derivatives as potent antitumor agents.
    Ma Z; Huang Y; Wan K; Zhu F; Sheng C; Chen S; Liu D; Dong G
    Bioorg Med Chem Lett; 2021 May; 40():127954. PubMed ID: 33744440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Water-soluble derivatives of evodiamine: Discovery of evodiamine-10-phosphate as an orally active antitumor lead compound.
    Chen S; Bi K; Wu S; Li Y; Huang Y; Sheng C; Dong G
    Eur J Med Chem; 2021 Aug; 220():113544. PubMed ID: 34052678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of Evodiamine-Glucose Conjugates with Improved
    Wu Z; Chen S; Chen Z; Dong G; Xu D; Sheng C
    J Med Chem; 2024 May; 67(9):7373-7384. PubMed ID: 38646851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scaffold overlay of flavonoid-inspired molecules: Discovery of 2,3-diaryl-pyridopyrimidin-4-imine/ones as dual hTopo-II and tubulin targeting anticancer agents.
    Saini M; Paul S; Acharya A; Acharya SS; Kundu CN; Guchhait SK
    Bioorg Chem; 2024 Nov; 152():107738. PubMed ID: 39182257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer.
    Liang Z; Lei F; Deng J; Zhang H; Wang Y; Li J; Shi T; Yang X; Wang Z
    Eur J Med Chem; 2022 Jan; 228():113960. PubMed ID: 34774339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel bis-evodiamine derivatives with potent antitumor activity.
    Liang H; Wang W; Zhu F; Chen S; Liu D; Sheng C
    Bioorg Med Chem; 2022 Jul; 65():116793. PubMed ID: 35550978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents.
    Dong G; Sheng C; Wang S; Miao Z; Yao J; Zhang W
    J Med Chem; 2010 Nov; 53(21):7521-31. PubMed ID: 20942490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel indolizino[8,7-b]indole hybrids as anti-small cell lung cancer agents: Regioselective modulation of topoisomerase II inhibitory and DNA crosslinking activities.
    Chang SM; Christian W; Wu MH; Chen TL; Lin YW; Suen CS; Pidugu HB; Detroja D; Shah A; Hwang MJ; Su TL; Lee TC
    Eur J Med Chem; 2017 Feb; 127():235-249. PubMed ID: 28064078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Indolo[3,2-
    Wang B; Wu S; Jia S; Ruan X; Sheng C; Zhou Q
    J Med Chem; 2024 Aug; 67(16):14155-14174. PubMed ID: 39106476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure-activity relationship analysis and biological evaluations.
    Dong G; Wang S; Miao Z; Yao J; Zhang Y; Guo Z; Zhang W; Sheng C
    J Med Chem; 2012 Sep; 55(17):7593-613. PubMed ID: 22867019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N(14)-substituted evodiamine derivatives as dual topoisomerase 1/tubulin-Inhibiting anti-gastrointestinal tumor agents.
    Deng J; Long L; Peng X; Jiang W; Peng Y; Zhang X; Zhao Y; Tian Y; Wang Z; Zhuo L
    Eur J Med Chem; 2023 Jul; 255():115366. PubMed ID: 37099835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor Activity of Asperphenin A, a Lipopeptidyl Benzophenone from Marine-Derived
    Bae SY; Liao L; Park SH; Kim WK; Shin J; Lee SK
    Mar Drugs; 2020 Feb; 18(2):. PubMed ID: 32069904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rational design strategy of the novel topoisomerase II inhibitors for the synthesis of the 4-O-(2-pyrazinecarboxylic)-4'-demethylepipodophyllotoxin with antitumor activity by diminishing the relaxation reaction of topoisomerase II-DNA decatenation.
    Zhao W; Chen L; Li HM; Wang DJ; Li DS; Chen T; Yuan ZP; Tang YJ
    Bioorg Med Chem; 2014 Jun; 22(11):2998-3007. PubMed ID: 24775914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and bioactivity study of evodiamine derivatives as multifunctional agents for the treatment of hepatocellular carcinoma.
    Fan X; Deng J; Shi T; Wen H; Li J; Liang Z; Lei F; Liu D; Zhang H; Liang Y; Hao X; Wang Z
    Bioorg Chem; 2021 Sep; 114():105154. PubMed ID: 34378540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel antitumor indolizino[6,7-b]indoles with multiple modes of action: DNA cross-linking and topoisomerase I and II inhibition.
    Chaniyara R; Tala S; Chen CW; Zang X; Kakadiya R; Lin LF; Chen CH; Chien SI; Chou TC; Tsai TH; Lee TC; Shah A; Su TL
    J Med Chem; 2013 Feb; 56(4):1544-63. PubMed ID: 23360284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamellarin-inspired potent topoisomerase I inhibitors with the unprecedented benzo[g][1]benzopyrano[4,3-b]indol-6(13H)-one scaffold.
    Fukuda T; Nanjo Y; Fujimoto M; Yoshida K; Natsui Y; Ishibashi F; Okazaki F; To H; Iwao M
    Bioorg Med Chem; 2019 Jan; 27(2):265-277. PubMed ID: 30553626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of novel benzodiazepine derivatives as anticancer agents through inhibition of tubulin polymerization in vitro and in vivo.
    Pang Y; Lin H; Ou C; Cao Y; An B; Yan J; Li X
    Eur J Med Chem; 2019 Nov; 182():111670. PubMed ID: 31499359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
    Kassab AE; Gedawy EM
    Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.